期刊文献+

复方尿囊素与铋剂四联十日疗法治疗H.pylori阳性慢性胃炎患者的效果对比 被引量:5

下载PDF
导出
摘要 目的观察复方尿囊素与铋剂四联疗法治疗H.pylori阳性慢性胃炎的治疗效果。方法将经胃镜诊断为H.pylori阳性慢性胃炎患者94例随机分为复方尿囊素组和铋剂组,每组47例。复方尿囊素组患者给予奥美拉唑20 mg/次,2次/d,四环素0.5 g/次,3次/d,呋喃唑酮0.1 g/次,3次/d,复方尿囊素3片/次,3次/d;铋剂组患者给予奥美拉唑20 mg/次,2次/d,四环素0.5 g/次,3次/d,呋喃唑酮0.1 g/次,3次/d,枸橼酸铋钾胶囊110 mg/次,4次/d。比较2组患者H.pylori根除率,临床症状改善效果,临床症状改善时间,不良反应和治疗后半年复发情况。结果复方尿囊素组患者H.pylori根除率、治疗有效率和显效率显著高于铋剂组(P<0.05)。复方尿囊素组患者上腹痛、腹胀、嗳气和反胃等临床症状改善时间显著低于铋剂组(P<0.01)。复方尿囊素组患者不良反应与铋剂组差异无统计学意义(P>0.05)。复方尿囊素组患者半年后复发率显著低于铋剂组(P<0.05)。结论复方尿囊素四联疗法治疗H.pylori阳性慢性胃炎的治疗效果更佳。
出处 《河北医药》 CAS 2015年第8期1172-1174,共3页 Hebei Medical Journal
  • 相关文献

参考文献13

  • 1Malfertheiner P,Megraud F,O’Morain CA,et al.Management of Helicobacter pylori infection—the Maastricht IV/Florence consensus report.Gut,2012,61:646-664.
  • 2汪文渊,蔡晓林,沈辩琴.24014例胃镜检查结果分析[J].安徽医学,2011,32(7):954-956. 被引量:17
  • 3Inoue I,Mukoubayashi C,Yoshimura N,et al.Elevated risk of colorectal adenoma with Helicobacter pylori‐related chronic gastritis:A population‐based case‐control study.International Journal of Cancer,2011,129:2704-2711.
  • 4Basu PP,Rayapudi K,Pacana T,et al.A randomized study comparing levofloxacin,omeprazole,nitazoxanide,and doxycycline versus triple therapy for the eradication of Helicobacter pylori.The American journal of gastroenterology,2011,106:1970-1975.
  • 5Mendis AHW,Marshall BJ.Helicobacter pylori and bismuth.John Wiley&Sons Ltd,Singapore,2011,31:796-800.
  • 6李秀青,吴友山,潘丽娟,陶志强.复方尿囊素片治疗胃溃疡疗效及机制研究[J].山西医药杂志(下半月),2011,40(5):471-472. 被引量:3
  • 7BuonavolontàR,Miele E,Russo D,et al.Helicobacter pylori Chronic Gastritis in Children:To Eradicate or Not to Eradicate?The Journal of pediatrics,2011,159:50-56.
  • 8Home MMP.Gastric Intestinal Metaplasia and Early Gastric Cancer in the West:A Changing Paradigm.Gastroenterology&Hepatology,2014,10:363-368.
  • 9Matsushima K,Isomoto H,Inoue N,et al.MicroRNA signatures in Helicobacter pylori-infected gastric mucosa.International Journal of Cancer,2011,128:361-370.
  • 10Cullen TW,Giles DK,Wolf LN,et al.Helicobacter pylori versus the host:remodeling of the bacterial outer membrane is required for survival in the gastric mucosa.PLo S pathogens,2011,7:2454-2460.

二级参考文献26

  • 1程留芳,赵永伟,孙国辉,郭荣斌,柴国君,令狐恩强,刘吉勇,崔义,周曾芬.尿囊素铝颗粒治疗胃炎及消化性溃疡的疗效及安全性[J].中国新药杂志,2004,13(11):1043-1046. 被引量:14
  • 2范晓,徐杨.前列腺素及胃细胞保护作用[J].中南药学,2006,4(6):460-463. 被引量:4
  • 3付善云,王畅.1056例胃病患者电子胃镜检查结果分析[J].贵州医药,2007,31(3):272-273. 被引量:4
  • 4Guth PH, Paulsen G, Nagata H. Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rat : effect of pros- taglandin cytoprotection. Gastroenterology, 1984, 87 ( 5 ) : 1083- 1090.
  • 5Tulassay Z, Hersz6nyi L. Gastric mucosal defense and cytoprotec- tion. Best Pract Res Clin Gastroenterol, 2010, 24(2) :99-108.
  • 6Musumba C, Pn'tchard DM, Pirmohamed M. Review article: cel- lular and molecular mechanisms of NSAID-induced peptic ulcers. Aliment Pharmacol Ther, 2009, 30 (6) : 517-531.
  • 7Laine L, Takeuehi K, Tamawski A. Gastric mucosal defense and eytoprotection: bench to bedside. Gastroenterology, 2008, 135 ( 1 ) :41-60.
  • 8Ham M, Kaunitz JD. Gastroduodenal defense. Curr Opin Gastro- enterol, 2007, 23 ( 6 ) : 607-616.
  • 9Ohbayashi S, Misaki N, Bando K, et al. The effect of aldioxa on the formation of gastritis induced with sodium hydroxide. Nippon Yakurigaku Zasshi, 1990, 96 (5) :255-265.
  • 10成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:517

共引文献62

同被引文献44

二级引证文献56

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部